MedPath

Efficacy of drug Ondansetron for prevention of low blood pressure (hypotension)

Phase 4
Conditions
Health Condition 1: I952- Hypotension due to drugs
Registration Number
CTRI/2024/04/066242
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA Class I

Exclusion Criteria

Patient’s refusal

Infection at the site

Coagulation abnormality

Allergy to study drugs

Patient receiving Ondansetron

Repeat or failed spinal

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath